Financial Lp Hrt Purchases 137,541 Shares of NewGenIvf Group (NASDAQ:NIVF) Stock

NewGenIvf Group Limited (NASDAQ:NIVF) major shareholder Financial Lp Hrt purchased 137,541 shares of the company’s stock in a transaction that occurred on Friday, May 22nd. The stock was acquired at an average price of $0.99 per share, for a total transaction of $136,165.59. Following the purchase, the insider owned 111,885 shares in the company, valued at $110,766.15. This trade represents a -536.10% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Tuesday, May 26th, Financial Lp Hrt purchased 27,993 shares of NewGenIvf Group stock. The stock was acquired at an average price of $0.92 per share, for a total transaction of $25,753.56.

NewGenIvf Group Stock Up 9.6%

NIVF traded up $0.08 during trading hours on Wednesday, reaching $0.86. The company’s stock had a trading volume of 491,241 shares, compared to its average volume of 1,415,830. The company has a quick ratio of 2.98, a current ratio of 3.12 and a debt-to-equity ratio of 0.16. The company’s 50-day moving average is $1.71 and its 200-day moving average is $7.16. NewGenIvf Group Limited has a 52 week low of $0.72 and a 52 week high of $1,839.00.

NewGenIvf Group (NASDAQ:NIVF) last posted its quarterly earnings data on Tuesday, March 31st. The company reported ($287.24) earnings per share for the quarter. The business had revenue of $1.42 million during the quarter. Sell-side analysts forecast that NewGenIvf Group Limited will post 4.74 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a research report on Monday, April 27th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Sell”.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.